Geode Capital Management, LLC Lian Bio Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$1.33 - $4.6 $7,358 - $25,451
5,533 Added 28.38%
25,027 $111,000
Q2 2023

Aug 11, 2023
BUY
$1.79 - $2.85 $7,160 - $11,400
4,000 Added 25.82%
19,494 $44,000
Q1 2023

May 15, 2023
BUY
$1.57 - $2.66 $24,325 - $41,214
15,494 New
15,494 $30,000

Others Institutions Holding LIAN

# of Institutions
3
Shares Held
1.1M
Call Options Held
0
Put Options Held
0
View Full List

About LianBio

LIAN Quotes by TradingView
  • Ticker LIAN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,354,000
  • Market Cap $32.5M
  • Description
  • LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...
More about LIAN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email